Startups channel feed

Met­sera part­ners with Am­neal to man­u­fac­ture obe­si­ty drugs, and Clive Mean­well hands over CEO role

7 months ago
Deals
Manufacturing

En­so­ma shut­ters Copen­hagen site from its Twelve Bio ac­qui­si­tion

7 months ago
People

DCVC Bio reels in $400M third fund

7 months ago
Financing

Rivus de­tails weight loss da­ta in heart fail­ure pa­tients and preps for new fundraise

7 months ago
R&D

Lil­ly-part­nered ra­dio­phar­ma start­up Ak­tis On­col­o­gy rais­es $175M

7 months ago
Financing
Pharma

The End­points 11 win­ners: Big bets on AI, new fron­tiers in edit­ing, a neu­ro re­nais­sance and Chi­nese chem­istry

7 months ago
Special

End­points 11 win­ner MediLink Ther­a­peu­tics: Chi­na start­up helps pow­er the ADC re­nais­sance

7 months ago
Special

End­points 11 win­ner Li­for­di Im­munother­a­peu­tics: Us­ing an­ti­bod­ies to de­liv­er po­tent steroids di­rect­ly to im­mune cells

7 months ago
Special

End­points 11 win­ner Iambic Ther­a­peu­tics: En­ter­ing the ‘show-me’ era for AI

7 months ago
Special

End­points 11 win­ner Car­du­ri­on Phar­ma­ceu­ti­cals: A shot at one of heart dis­ease’s 'un­drug­gable' tar­gets

7 months ago
Special

End­points 11 win­ner As­cid­i­an Ther­a­peu­tics: A search-and-re­place tech­nol­o­gy comes to RNA

7 months ago
Special

End­points 11 win­ner Met­sera: Clive Mean­well wa­gers on obe­si­ty af­ter Med­i­cines Com­pa­ny suc­cess

7 months ago
Special

End­points 11 win­ner For­ma­tion Bio: A Sil­i­con Val­ley-fu­eled uni­corn aim­ing to be the next Roivant — or more

7 months ago
Special

End­points 11 win­ner Cap­stan Ther­a­peu­tics: Try­ing to win the in vi­vo CAR-T race

7 months ago
Special

End­points 11 win­ner Mi­rador Ther­a­peu­tics: Ap­ply­ing pre­ci­sion med­i­cine to im­mune dis­ease

7 months ago
Special

End­points 11 win­ner Sea­port Ther­a­peu­tics: The Karuna team is back with an­oth­er big bet in neu­ro­science

7 months ago
Special

In­sil­i­co Med­i­cine, an ear­ly force in AI-dri­ven drug R&D, lets IPO plans pe­ter out for sec­ond year in a row

7 months ago
Financing
China

ARCH, biotech's star slug­ger, snags an­oth­er $3B for 13th fund

7 months ago
Financing

Flag­ship launch­es start­up to de­sign and make lipid nanopar­ti­cles for ge­net­ic med­i­cines

7 months ago
Financing
Manufacturing

Barcelona VC firm Asabys rais­es sec­ond fund, adding to Eu­rope’s biotech fund­ing scene

7 months ago
Financing

Next-gen obe­si­ty biotech BioAge Labs to raise $198M in IPO

7 months ago
Financing

Ital­ian gene ther­a­py start­up nabs $52M for rare ge­net­ic dis­ease that Mod­er­na is work­ing on

7 months ago
Financing
Cell/Gene Tx

Check­ing up on past End­points 11 win­ners: Who went pub­lic, who got bought and who's still work­ing

7 months ago
Special

Clive Mean­well's new obe­si­ty biotech, Met­sera, un­veils ear­ly GLP-1 da­ta with an eye on Phase 3 next year

7 months ago
R&D
First page Previous page 891011121314 Next page Last page
A service from the Financial Times